My PCR
Create Account
Logo PCR
Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

422 results

Clinical cases - Coronary interventions - Session 1

06 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

Abstracts - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

Outcome of women in different cardiovascular interventions

06 Oct 2022 – From AICT-AsiaPCR 2022

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

Durable polymer vs. biodegradable polymer DES in patients with ACS undergoing complex PCI: A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

30 Aug 2022

The HOST-REDUCE-POLYTECH-ACS trial was a randomised, parallel-group multicentre trial with a 2x2 factorial design testing two independent hypotheses, one of which was the non-inferiority of durable polymer drug-eluting stents (DP-DES) to biodegradable polymer drug-eluting stents (BP-DES) in patients with ACS. In this post-hoc analysis, the authors...

Nicola Ryan

Reviewer

Nicola Ryan
A post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial

FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

24 Aug 2022

The primary objective of the study was to assess whether an IVUS-based stent optimization provided an incremental value in terms of vessel-related adverse event occurrence in patients presenting with low post-PCI FFR (<0.90).

Simone Fezzi

Reviewer

Simone Fezzi
M. Pighi

Reviewer

Michele Pighi
FFR-guided PCI optimization directed by high-definition IVUS versus standard of care - the FFR-REACT trial

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD

PCI of calcified left main – how to do safely?

12 Nov 2019

View this replay of a LIVE Webinar - PCI of calcified left main – how to do safely?, with E. Barbato, C. K. Naber and F. Ribichini.

PCI of calcified left main – how to do safely?

Complex double stent techniques in left main disease

08 Aug 2019

View this replay of a LIVE Webinar - Complex double stent techniques in left main disease, with G. G. Toth, C. K. Naber and M. Noc.

Complex double stent techniques in left main disease